Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Hepatol. 2018 Apr 12;69(2):396–405. doi: 10.1016/j.jhep.2018.03.031

Table 5.

Univariable regression analysis of laboratory and clinical parameters associated with FGF19

Variables B SE p-valuea R2
Bilirubin (mg/dl) 0.134 0.066 0.043 0.033
GGT (IU/L) 13.90 6.059 0.025 0.082
ALT (IU/L) 0.135 0.316 0.669 0.002
AST (IU/L) −0.681 1.250 0.587 0.002
INR −0.006 0.004 0.113 0.020
Fibrosis stageb −0.017 0.008 0.031 0.070
PMN infiltrationc −0.018 0.006 0.005 0.118

Notes:

a

Significance is indicated in bold. Univariable regression analysis.

b

Fibrosis stages were classified as 0 = no fibrosis, 1 = portal fibrosis, 2 = expansive periportal fibrosis, 3 = bridging fibrosis, 4 = cirrhosis.

c

PMN infiltration was classified as 0 = No PMN infiltration, 1 = mild PMN infiltration, 2 = severe PMN infiltration.

Abbreviations:

B=non-standardized regression coefficient, SE=Standard Error, R2=coefficient of determination.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; FGF19, fibroblast growth factor 19; GGT, gamma glutamyl transferase; INR, international normalized ratio; PMN, polymorphonuclear cells.